ZENROCK LABORATORIES LTD

Executive Summary

ZENROCK LABORATORIES LTD exhibits strong asset backing and liquidity, underpinned by significant intangible asset investments and positive working capital. However, the company currently operates with negative shareholders' funds due to accumulated losses typical of a startup phase. Strategic focus on profitability, managing financial risks related to shareholder loans and volatile crypto assets, and maintaining liquidity will be critical for its financial wellness and long-term viability.

ZENROCK LABORATORIES LTD - Analysis Report

Company Number: 15425285

Analysis Date: 2025-07-29 12:43 UTC

Financial Health Assessment for ZENROCK LABORATORIES LTD (as at 31 December 2024)

---

1. Financial Health Score: C

Explanation:
ZENROCK LABORATORIES LTD is a newly incorporated private limited company with significant fixed assets primarily in intangible assets (notably crypto assets and intellectual property). The company shows a strong asset base and positive net current assets, indicating liquidity. However, the shareholders' funds are negative, largely due to accumulated losses in the profit and loss account. The balance sheet reflects a complex capital structure with revaluation reserves and loans from shareholders, indicating early-stage investment but also potential financial stress. Overall, the score "C" reflects a company with solid asset backing but early signs of financial strain and risk.

---

2. Key Vital Signs

Vital Sign	Value	Interpretation
Fixed Assets	£2,121,083	Significant investment in intangible assets (IP and crypto), showing capital-intensive operations.
Current Assets	£1,666,484	Healthy short-term resources, including cash (£287k) and debtors (£1.37m), indicating liquidity.
Current Liabilities	£433,011	Manageable short-term obligations; net current assets positive at £1.23m, showing good working capital.
Net Assets	£3,114,848	Positive net assets indicating assets exceed liabilities overall.
Shareholders’ Funds	-£4,379,302	Deficit due to accumulated losses, a red flag suggesting the company has yet to generate sustainable profits.
Revaluation Reserve	£1,438,152	Gains on crypto assets recognized in equity, reflecting volatile but potentially valuable asset base.
Loan from Shareholders	£243,800 (interest bearing)	Indicates reliance on shareholder loans, which may pose financial risk if not managed well.
Average Number of Employees	9	Small team, consistent with micro/small company status.

---

3. Diagnosis: What the Financial Data Reveals

ZENROCK LABORATORIES LTD is in the early stages of its business lifecycle, as indicated by its recent incorporation in January 2024. The company has invested heavily in intangible assets, especially crypto assets and intellectual property, which form the core of its asset base. The large fixed asset figure suggests a capital-intensive setup, likely necessary for its IT service activities (SIC 62090).

The positive net current assets and cash balance suggest the company has a "healthy cash flow" in the short term and sufficient liquidity to meet immediate obligations. This is a vital sign indicating the company is not currently in distress.

However, the "symptoms of distress" lie in the negative shareholders’ funds of over £4 million, which points to accumulated losses or expenses exceeding income to date. This is common for startups investing heavily upfront but is a risk factor if profitability does not improve.

The presence of an interest-bearing loan from shareholders adds financial pressure due to future repayment and interest expense obligations.

The revaluation of crypto assets has boosted equity through a revaluation reserve, but crypto assets are volatile and can introduce financial uncertainty if market conditions change.

Overall, the company shows a strong asset base and liquidity but faces challenges in profitability and accumulated losses, requiring careful management of expenditures and growth.

---

4. Recommendations: Specific Actions to Improve Financial Wellness

• Improve Profitability:
  Focus on converting the intangible assets and intellectual property into revenue streams. Prioritize sales and service delivery to generate operating profits and reduce the accumulated loss reserve.

• Manage Shareholder Loans:
  Plan for repayment or refinancing of shareholder loans to avoid liquidity strain, especially since the loan is interest-bearing at 15%, which is a high cost.

• Monitor Asset Valuation Risks:
  Given the significant crypto asset holdings and their revaluation impact, implement risk management strategies to hedge against volatility and avoid sudden impairments affecting equity and earnings.

• Maintain Healthy Working Capital:
  Continue managing debtors and creditors efficiently to preserve the positive net current assets, ensuring the company remains able to meet short-term obligations comfortably.

• Financial Reporting & Transparency:
  As the company grows, consider moving beyond exemption from audit to enhance credibility with investors and stakeholders, providing assurance on financial health.

• Strategic Growth Planning:
  Develop a clear business plan outlining milestones for achieving profitability and cash flow sustainability, which will help guide investment and operational decisions.

---